A 2025 analysis by the Employers Health Coalition found that 64% of large employers (5,000+ employees) excluded GLP-1 medications for obesity from their health plans, citing projected costs of $12,000 to $15,000 per patient per year (Jain et al., Health Affairs 2025)
Recognising Symptoms of Delayed Gastric Emptying on Ozempic Patients taking Ozempic should be aware of symptoms that may indicate significant delayed gastric emptying, whether as an expected medication effect or potentially more concerning gastroparesis
Lipo-C as a compounded formulation is not FDA approved
A diet high in carbohydrates increases circulating levels of insulin, which promotes fat storage, increased hunger, and cravings
The research discussed here was conducted in animal and cell-culture models
And calories require work on the human to go and get them, to forage and hunt